Loading…
Aurora Cannabis Inc
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
▼ -93.8% over 5Y.
today you would have $59.25▼ -94.1%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2026 | 2025 | 2024 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $4.10 | $4.22 | $4.25 | $9.23 | |
| P/E | — | — | 105.5x | — | — |
| P/S | 0.8x | 0.8x | 0.8x | 0.9x | 1.2x |
| P/B | 0.4x | 0.5x | 0.4x | 0.4x | 0.4x |
| EPS | -$2.14 | $0.04 |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| PYXSPyxis Oncology, Inc. | $3.23 | — | 17.9x | — | -179.10% | $269.41M |
| SRZNSurrozen, Inc. | $22.42 | — | — | — | — | $263.51M |
| WHWKWhitehawk Therapeutics, Inc. | $4.62 | — | 1.9x | — | -44.98% | $263.38M |
| ACIUAC Immune SA | $2.73 |
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty's, Whistler, and WMMC. The company also engages in pharmacy activities. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.
Company description provided by Yahoo Finance.
| -$1.52 |
| -$79.90 |
| Profit margin | -34.06% | -42.41% | 0.55% | -25.71% | -776.02% |
| ROE | -19.47% | -26.56% | 0.28% | -12.38% | -259.52% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 6.3x |
| — |
| -78.53% |
| $271.44M |
| TRDAEntrada Therapeutics, Inc. | $7.00 | — | 0.9x | — | -54.09% | $272.56M |
| ANIKAnika Therapeutics, Inc. | $20.38 | — | 2.0x | — | -2.19% | $272.68M |